Virios Fibromyalgia Drug Fails Phase IIb And Firm Says COVID-19 May Be To Blame

 
• By Jessica Merrill
  
thumb up and down
Virios saw different results in different cohorts in Phase IIb • Source: Shutterstock

More from Clinical Trials

More from R&D